Nebangwa DN, Shey RA, Shadrack DM, Shintouo CM, et al. Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials. PLoS One 2024;19:e0312315.
PMID: 39432476